Clinical Trial Update: Lipid Management in Clinical Practice (MK-0524A-115)

View source ↗

Summary

Completed results from Merck's MK-0524A-115 trial on lipid management in clinical practice; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• MK-0524A (Extended Release Niacin/Laropiprant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Lipid Metabolism Disorder | Status: COMPLETED | Results posted: 2012-03-07